Biotech vs COVID-19: The Role of Emerging Tech in the Fight Against COVID-19 (Part 2)

Jun 5, 2020 · 51m 23s
Biotech vs COVID-19: The Role of Emerging Tech in the Fight Against COVID-19 (Part 2)
Description

This is part 2 of our event with BioIDEA: Biotech vs COVID-19 BioIDEA and EVQLV hosted a panel discussion and Q&A on the role of emerging technologies in the fight...

show more
This is part 2 of our event with BioIDEA: Biotech vs COVID-19

BioIDEA and EVQLV hosted a panel discussion and Q&A on the role of emerging technologies in the fight against COVID-19.

Our panelists included Elena Diez Cecilia, Director of Business Development and R&D Strategy at A2A Pharmaceuticals, Ed Painter, Chairman and CIO of A2A Pharmaceuticals; Peter Leonardi, CEO and Founder of OmniCyte; and our very own Andrew Satz, CEO and Co-Founder of EVQLV.

More from BioIDEA: https://bioidea.co/
More from A2A Pharmaceuticals: https://a2apharma.com/
More form OmniCyte: https://omnicyte.com/
More from EVQLV: https://evqlv.com/
show less
Information
Author Daniel Gigante
Organization Daniel Gigante
Website -
Tags

Looks like you don't have any active episode

Browse Spreaker Catalogue to discover great new content

Current

Podcast Cover

Looks like you don't have any episodes in your queue

Browse Spreaker Catalogue to discover great new content

Next Up

Episode Cover Episode Cover

It's so quiet here...

Time to discover new episodes!

Discover
Your Library
Search